This week's FierceBiotech is brought to you by Rho.
Not rendering correctly? View this email as a web page here.
Hi Colleague,
Getting a new product from the bench into the clinic is a complex endeavor. This webinar provides an overview of the clinical, nonclinical, CMC, and regulatory activities necessary for a successful IND submission, including:
Developing the target product profile
Determining the starting dose for phase 1 studies
Ensuring clinical trial material and placebo are available for clinical studies
Rho, Inc. 6330 Quadrangle Drive Chapel Hill, NC 27517 United States
Want to reach 150,000+ FierceBiotech subscribers with your own message? Contact aalcover@fiercemarkets.com or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech. Click here to unsubscribe.
